252 related articles for article (PubMed ID: 7853171)
21. Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression.
Piletz JE; Halaris A; Ernsberger PR
Crit Rev Neurobiol; 1994; 9(1):29-66. PubMed ID: 8828003
[TBL] [Abstract][Full Text] [Related]
22. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
Renouard A; Widdowson PS; Millan MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
[TBL] [Abstract][Full Text] [Related]
23. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
[TBL] [Abstract][Full Text] [Related]
24. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction.
Raasch W; Schäfer U; Qadri F; Dominiak P
Br J Pharmacol; 2002 Feb; 135(3):663-72. PubMed ID: 11834614
[TBL] [Abstract][Full Text] [Related]
25. Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain.
Piletz JE; Ordway GA; Zhu H; Duncan BJ; Halaris A
Neuropsychopharmacology; 2000 Dec; 23(6):697-708. PubMed ID: 11063925
[TBL] [Abstract][Full Text] [Related]
26. Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test.
Zeidan MP; Zomkowski AD; Rosa AO; Rodrigues AL; Gabilan NH
Eur J Pharmacol; 2007 Jun; 565(1-3):125-31. PubMed ID: 17445795
[TBL] [Abstract][Full Text] [Related]
27. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
28. Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter.
Reis DJ; Regunathan S
Ann N Y Acad Sci; 1999 Jun; 881():65-80. PubMed ID: 10415899
[TBL] [Abstract][Full Text] [Related]
29. Characterization of [(3)H]idazoxan binding sites on human platelets.
Ruiz J; Barinagarrementeria G; Martín-Gómez JI; Callado LF; Meana JJ
Platelets; 2002 Jun; 13(4):241-6. PubMed ID: 12189026
[TBL] [Abstract][Full Text] [Related]
30. Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.
Radwanska A; Dlugokecka J; Wasilewski R; Kaliszan R
J Physiol Pharmacol; 2009 Mar; 60(1):131-42. PubMed ID: 19439815
[TBL] [Abstract][Full Text] [Related]
31. Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors.
Dontenwill M; Vonthron C; Greney H; Magnier C; Heemskerk F; Bousquet P
Ann N Y Acad Sci; 1999 Jun; 881():123-34. PubMed ID: 10415908
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat.
Sun MK; Regunathan S; Reis DJ
Clin Exp Hypertens; 1995; 17(1-2):115-28. PubMed ID: 7735262
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of imidazoline I2 binding sites in pig brain.
Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
[TBL] [Abstract][Full Text] [Related]
34. An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine.
Wang H; Regunathan S; McGowan D; Bramwell S; Reis DJ
Neurochem Int; 1997 Jan; 30(1):85-94. PubMed ID: 9116591
[TBL] [Abstract][Full Text] [Related]
35. I1-imidazoline receptors: an update.
Bousquet P; Dontenwill M; Greney H; Feldman J
J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
[TBL] [Abstract][Full Text] [Related]
36. Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors.
Pinthong D; Wright IK; Hanmer C; Millns P; Mason R; Kendall DA; Wilson VG
Naunyn Schmiedebergs Arch Pharmacol; 1995 Jan; 351(1):10-6. PubMed ID: 7715734
[TBL] [Abstract][Full Text] [Related]
37. Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age.
Piletz JE; Andrew M; Zhu H; Feng YZ; Rains J; Halaris A
J Psychiatr Res; 1998; 32(2):55-64. PubMed ID: 9694001
[TBL] [Abstract][Full Text] [Related]
38. Clonidine displacement from type 1 imidazoline receptor by p-aminobenzamidine, the prototype of trypsin-like serine protease inhibitors.
Pallottini V; Marino M; Ascenzi P
IUBMB Life; 2002 Nov; 54(5):301-4. PubMed ID: 12587981
[TBL] [Abstract][Full Text] [Related]
39. LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptors.
Urosevic D; Schann S; Ehrhardt JD; Bousquet P; Greney H
Br J Pharmacol; 2004 Jun; 142(3):609-17. PubMed ID: 15178642
[TBL] [Abstract][Full Text] [Related]
40. Membrane localization and guanine nucleotide sensitivity of medullary I1-imidazoline binding sites.
Ernsberger P; Shen IH
Neurochem Int; 1997 Jan; 30(1):17-23. PubMed ID: 9116582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
